The Effect of Gemcitabine Plus Nab-paclitaxel as Secondary Chemotherapy in Advanced Pancreatic Cancer

NCT03401827 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Adenocarcinoma
Chemotherapy Effect

Interventions

DRUG: Chemotherapy (Gemcitabine + nab-paclitaxel)

Sponsor

Seoul National University Hospital